Biotech dominates Ireland's ATRP )Advanced Technology Research Programme) programme:
This article was originally published in Clinica
Over one third of proposals received by Enterprise Ireland's Advanced Technology Research Programme (ATRP) 2001 were in the biotechnology field. Of the 172 proposals applying for a share of the I£11.2 million ($12.3 million) fund, 61 were biotech-related projects. The average funding requested was I£300,000. The aim of the programme is to generate technologies, products or processes that help launch new high-tech companies and to promote industrial competitiveness, reports Irish Biotech News. The programme also provides support for the commercial exploitation of research results. The closing date for applications was May 21; their evaluation is currently underway.
You may also be interested in...
Pfizer is producing vaccine doses at scale now that it has buttoned down the manufacturing process.
As Chinese returnees transform their startups to fully-fledged biopharma operations with a full product lineup and the global market in sight, the journey has been filled with challenges. Based on interviews and on-the-ground reporting, this new series takes a closer look at several companies' experiences.
US FDA Will Need About A Week To Complete COVID Vaccine Assessment Following Advisory Cmte., CBER’s Marks Says
Timeline is the most pessimistic public projection to date, but still incredibly fast. Clinical trial patients on placebo could be contacted and offered the vaccine after an EUA is granted.